TrialTrials2021

An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR).

Stephen I Walimbwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.